Therapeutic Targeting of Cancer Stem Cells in Lung, Head and Neck, and Bladder Cancers

Sarah E Mudra1, Pritam Sadhukhan2, M Talha Ugurlu2

  • 1School of Medicine, University of Louisville, Louisville, KY 40202, USA.

Cancers
|October 23, 2021
PubMed

Insights

Cancer stem cells (CSCs) drive therapy resistance in solid tumors. Novel targeted agents are crucial to overcome this resistance and improve cancer treatment outcomes.

Area of Science:

  • Oncology
  • Cancer Biology
  • Stem Cell Research

Background:

  • Therapy resistance is a major challenge in treating solid malignancies.
  • Cancer stem cells (CSCs) are a resistant subpopulation crucial for tumor recurrence and metastasis.
  • Targeting CSCs is essential for overcoming therapeutic resistance.

Purpose of the Study:

  • To review novel targeted agents for combating cancer stem cells (CSCs).
  • To highlight the role of CSCs in intrinsic and acquired therapy resistance.
  • To discuss strategies for selectively targeting CSCs in resistant tumors.

Main Methods:

  • Literature review of novel targeted agents against CSCs.
  • Analysis of signaling pathways (WNT/β-catenin, Notch, Hippo, Hedgehog) involved in CSC generation and resistance.
  • Examination of CSC interaction with the tumor microenvironment and immune system.

Main Results:

  • CSCs possess self-renewal and differentiation capacities, contributing to therapeutic resistance.
  • Deregulated signaling pathways are implicated in CSC generation and resistance.
  • CSCs influence carcinogenesis, metastasis, and tumor recurrence.

Conclusions:

  • Novel targeted agents are fundamental for advancing cancer treatment against resistant tumors.
  • Understanding CSC biology and resistance mechanisms is key to developing effective therapies.
  • Selective targeting of CSCs offers a promising strategy to overcome intrinsic and acquired resistance.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.9K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.1K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.3K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.2K